Prolactinoma epidemiology and demographics: Difference between revisions
Line 12: | Line 12: | ||
Prolactinomas rarely occur in children. | Prolactinomas rarely occur in children. | ||
==Prevelance== | ==Prevelance== | ||
The prevalence of prolactinoma in younger age group is 100 per 100,000 population.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref>[[Autopsy]] studies indicate that 6-25% of the U. S. population have small pituitary tumors. Forty percent of these pituitary tumors produce prolactin, but most are not considered clinically significant. Clinically significant [[pituitary]] tumors affect the health of approximately 14 out of 100,000 people in United States. | The [[prevalence]] of prolactinoma in younger age group is 100 per 100,000 population.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref>[[Autopsy]] studies indicate that 6-25% of the U. S. population have small pituitary tumors. Forty percent of these pituitary tumors produce prolactin, but most are not considered clinically significant. Clinically significant [[pituitary]] tumors affect the health of approximately 14 out of 100,000 people in United States. | ||
In nonselected surgical series, this tumor accounts for approximately 25-30% of all pituitary [[adenomas]]. Some growth hormone (GH)–producing tumors also co-secrete prolactin. Microprolactinomas are much more common than macroprolactinomas. | In nonselected surgical series, this tumor accounts for approximately 25-30% of all pituitary [[adenomas]]. Some growth hormone (GH)–producing tumors also co-secrete prolactin. [[Microprolactinomas]] are much more common than [[macroprolactinomas]]. | ||
== References == | == References == |
Revision as of 15:27, 10 September 2015
Prolactinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Prolactinoma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Prolactinoma epidemiology and demographics |
Risk calculators and risk factors for Prolactinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
The prevalence of prolactinoma in younger age group is 100 per 100,000 individuals.[1]Autopsy studies indicate that 6-25% of the U. S. population have small pituitary tumors. Forty percent of these pituitary tumors produce prolactin, but most are not considered clinically significant. Clinically significant pituitary tumors affect approximately 14 out of 100,000 people in United States.
Epidemiology and Demographics
Although small benign pituitary tumors are fairly common in the general population, symptomatic prolactinomas are uncommon.
Gender
Prolactinomas occur more often in women than men.
Age
Prolactinomas rarely occur in children.
Prevelance
The prevalence of prolactinoma in younger age group is 100 per 100,000 population.[1]Autopsy studies indicate that 6-25% of the U. S. population have small pituitary tumors. Forty percent of these pituitary tumors produce prolactin, but most are not considered clinically significant. Clinically significant pituitary tumors affect the health of approximately 14 out of 100,000 people in United States. In nonselected surgical series, this tumor accounts for approximately 25-30% of all pituitary adenomas. Some growth hormone (GH)–producing tumors also co-secrete prolactin. Microprolactinomas are much more common than macroprolactinomas.
References
- ↑ 1.0 1.1 Ciccarelli A, Daly AF, Beckers A (2005). "The epidemiology of prolactinomas". Pituitary. 8 (1): 3–6. doi:10.1007/s11102-005-5079-0. PMID 16411062.